Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

fool.com - Brendan Coffey - Moderna vs. Recursion: Which Cutting-Edge Pharma Stock Is a Better Buy in 2026?
Moderna vs. Recursion: Which Cutting-Edge Pharma Stock Is a Better Buy in 2026?
The Motley Fool

As the biotechnology landscape shifts toward personalized medicine and advanced computing, investors are weighing established leaders against emerging tech-driven disruptors. Moderna (MRNA +9.99%) and Recursion Pharmaceuticals (RXRX +3.54%) offer…

thehindubusinessline.com - Nifty holds above 24,350 at noon; IT, Pharma and Financials lead broad rally
Nifty holds above 24,350 at noon; IT, Pharma and Financials lead broad rally
BusinessLine

Markets maintained firm gains through the first half of trade on Friday, with the Sensex up 539.09 points or 0.70 per cent at 78,041.21 and the Nifty 50 higher by 182.10 points or 0.75 per cent at 24,357.80, as of 12.55 PM. The session so far has…

sputnikglobe.com - Moscow's SEZ Pharma Players Pour 1.7× More Investments Into City's Economy
Moscow's SEZ Pharma Players Pour 1.7× More Investments Into City's Economy
Sputnik International

The top investor in January-March 2026 was a pharmaceutical company currently conducting clinical trials of a drug targeting 30 types of cancer. The resident company has also developed four biosimilars for the treatment of melanoma, non-small cell…

marketbeat.com - USS Investment Management Ltd Boosts Position in Royalty Pharma PLC $RPRX
USS Investment Management Ltd Boosts Position in Royalty Pharma PLC $RPRX
MarketBeat

USS Investment Management Ltd increased its position in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 21.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission.

rediff.com - Rediff News - Stock markets take winning run to 3rd day
Stock markets take winning run to 3rd day
Rediff.com

Benchmark equity indices Sensex and Nifty ended higher on Friday, extending their winning momentum to the third day running, amid a rally in IT stocks and a softer-than-expected US jobs data tempering expectations of near-term monetary tightening…

forbes.com - Christian Stadler - GTA 6 And Take-Two Interactive: The 'Rebel Strategy' Driving A Gaming Titan
GTA 6 And Take-Two Interactive: The 'Rebel Strategy' Driving A Gaming Titan
Forbes

Take-Two is a blockbuster machine with games like GTA 6 but also has annual revenue through sports and mobile games. SOPA Images/LightRocket via Getty Images Grand Theft Auto 6 is expected to sell up to 40 million copies in a single day when it…

theverge.com - Robert Hart - Anthropic wants to develop its own drugs
Anthropic wants to develop its own drugs
The Verge

The AI drug boom has a long way to go before reaching patients. The AI drug boom has a long way to go before reaching patients. If you buy something from a Verge link, Vox Media may earn a commission. See our ethics statement. Robert Hart is a…

seekingalpha.com - High Alpha Professor - Brookfield Renewable: Simplification Catalyst May Favor Brookfield Renewable Partners
Brookfield Renewable: Simplification Catalyst May Favor Brookfield Renewable Partners
Seeking Alpha

Brookfield Renewable Corporation is evaluating a merger with Brookfield Renewable Partners to create a single publicly traded entity. BEPC trades at a 7.7% premium to BEP despite identical economic exposure, payments, and platform access, largely…

dynamitenews.com - Donika Singh - What's powering India's stock market rally? Nifty and sensex post strong weekly gains | Dynamite News
What's powering India's stock market rally? Nifty and sensex post strong weekly gains | Dynamite News
News: Today's News Headlines & Daily Updates from Sports, Movies, Politics, Business | Dynamite News

Post Published By: Donika Singh Updated: 4 July 2026, 9:59 AM IST New Delhi: The Indian equity benchmarks posted a fourth consecutive week of gains, over sustained correction in crude oil prices and expectations of a more favourable global interest…

yahoo.com - Jabran Kundi - A $500 Million Funding Deal Could Make Mineralys Therapeutics (MLYS) Stock A Multibagger
A $500 Million Funding Deal Could Make Mineralys Therapeutics (MLYS) Stock A Multibagger
Yahoo!

Mineralys Therapeutics Inc. (NASDAQ: MLYS) is one of the 8 Hidden Multibagger Stocks to Buy Now. During the last few trading sessions, Mineralys Therapeutics Inc. (NASDAQ:MLYS) has seen positive momentum. On June 4, Goldman Sachs analyst Richard…

thehindubusinessline.com - India's luxury homebuyer is changing, and so is the market
India's luxury homebuyer is changing, and so is the market
BusinessLine

The face of India's luxury homebuyer is changing. For decades, the country's most expensive homes were the preserve of legacy business families and industrialists. Today, a different kind of buyer is walking into luxury sales offices —…

thehindu.com - Pti - Stock markets take winning run to third day; Sensex climbs 262 points
Stock markets take winning run to third day; Sensex climbs 262 points
The Hindu

Benchmark equity indices Sensex and Nifty ended higher on Friday (July 3, 2026), extending their winning momentum to the third day running, amid a rally in IT stocks and a softer-than-expected U.S. jobs data tempering expectations of near-term…

newswire.ca - Nanalysis Scientific Corp. - Nanalysis Announces Grant of Options and Restricted Share Units
Nanalysis Announces Grant of Options and Restricted Share Units
CNW

CALGARY, AB, July 3, 2026 /CNW/ - Nanalysis Scientific Corp. (the 'Company' or 'Nanalysis') (TSXV: NSCI, FRA: 1N1) announces the Company's Board of Directors has granted 100,000 stock options ('Options') to a director and officer of the Company…

rediff.com - Nandita Malik - Sensex, Nifty Extend Winning Streak on IT Stocks Rally, Global Rate Hopes
Sensex, Nifty Extend Winning Streak on IT Stocks Rally, Global Rate Hopes
Rediff.com

Indian benchmark equity indices, Sensex and Nifty, extended their winning streak for a third consecutive day, driven by a rally in IT stocks and global cues suggesting a more accommodative monetary policy after softer-than-expected US jobs data.

timeout.com - Nina Culley - −320°F, Sadler's Wells review: The latest bonkers spectacle from Japan's Hideki Noda is hilarious, visually stunning and way too long
−320°F, Sadler's Wells review: The latest bonkers spectacle from Japan's Hideki Noda is hilarious, visually stunning and way too long
Time Out

The latest bonkers spectacle from Japan's Hideki Noda is hilarious, visually stunning and way too long Theatre, Experimental Sadler's Wells, Clerkenwell Recommended The title of Hideki Noda's latest play is ‘minus three twenty Fahrenheit'…

Receive a Daily briefing on Pharma Industry News

Get Started